WO2017209553A3 - Method for screening antibody using patient-derived cells - Google Patents
Method for screening antibody using patient-derived cells Download PDFInfo
- Publication number
- WO2017209553A3 WO2017209553A3 PCT/KR2017/005766 KR2017005766W WO2017209553A3 WO 2017209553 A3 WO2017209553 A3 WO 2017209553A3 KR 2017005766 W KR2017005766 W KR 2017005766W WO 2017209553 A3 WO2017209553 A3 WO 2017209553A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patient
- derived cells
- screening antibody
- screening
- antigen
- Prior art date
Links
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018562986A JP6895460B2 (en) | 2016-06-03 | 2017-06-02 | Antibody screening method using patient-derived tumor spheroids |
US16/306,566 US11199536B2 (en) | 2016-06-03 | 2017-06-02 | Method for screening antibody using patient-derived tumor spheroids |
CN201780041974.6A CN109416364B (en) | 2016-06-03 | 2017-06-02 | Method for screening antibodies using patient-derived tumor spheres |
AU2017273169A AU2017273169B2 (en) | 2016-06-03 | 2017-06-02 | Method for screening antibody using patient-derived tumor spheroids |
CA3026236A CA3026236C (en) | 2016-06-03 | 2017-06-02 | Method for screening antibody using patient-derived tumor spheroids |
SG11201810779PA SG11201810779PA (en) | 2016-06-03 | 2017-06-02 | Method for screening antibody using patient-derived tumor spheroids |
EP17807046.2A EP3480598A4 (en) | 2016-06-03 | 2017-06-02 | Method for screening antibody using patient-derived cells |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20160069355 | 2016-06-03 | ||
KR10-2016-0069355 | 2016-06-03 | ||
KR10-2017-0069140 | 2017-06-02 | ||
KR1020170069140A KR101993892B1 (en) | 2016-06-03 | 2017-06-02 | Method of Screening Antibody Using Patient Derived Cell |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2017209553A2 WO2017209553A2 (en) | 2017-12-07 |
WO2017209553A3 true WO2017209553A3 (en) | 2018-01-18 |
Family
ID=60477675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2017/005766 WO2017209553A2 (en) | 2016-06-03 | 2017-06-02 | Method for screening antibody using patient-derived cells |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2017209553A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3115102A1 (en) | 2018-10-23 | 2020-04-30 | Regeneron Pharmaceuticals, Inc. | Anti-npr1 antibodies and uses thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020199212A1 (en) * | 2001-05-10 | 2002-12-26 | Saburo Sone | Non-human animal exhibiting bone metastasis of tumor cells and method of screening for bone metastasis inhibitors |
KR101096359B1 (en) * | 2005-11-08 | 2011-12-20 | 제넨테크, 인크. | Neuropilin Antagonists |
KR20120048563A (en) * | 2009-06-22 | 2012-05-15 | 번햄 인스티튜트 포 메디칼 리서치 | Methods and compositions using peptides and proteins with c-terminal elements |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
ATE87659T1 (en) | 1986-09-02 | 1993-04-15 | Enzon Lab Inc | BINDING MOLECULES WITH SINGLE POLYPEPTIDE CHAIN. |
DE3852304T3 (en) | 1987-03-02 | 1999-07-01 | Enzon Lab Inc | Organism as carrier for "Single Chain Antibody Domain (SCAD)". |
DE3852074D1 (en) | 1987-03-20 | 1994-12-15 | Creative Biomolecules Inc | METHOD FOR PURIFYING RECOMBINANT POLYPEPTIDES. |
JP2535066B2 (en) | 1987-03-20 | 1996-09-18 | クリエイティブ・バイオマリキュールズ・インコーポレーテッド | Leader sequence for recombinant protein production |
JPH02500329A (en) | 1987-05-21 | 1990-02-08 | クリエイテイブ・バイオマリキユールズ・インコーポレーテツド | Targeted multifunctional protein |
WO2011143408A1 (en) | 2010-05-13 | 2011-11-17 | Genentech, Inc. | Use of neuropilin-1 antagonists for the treatment of cancer |
-
2017
- 2017-06-02 WO PCT/KR2017/005766 patent/WO2017209553A2/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020199212A1 (en) * | 2001-05-10 | 2002-12-26 | Saburo Sone | Non-human animal exhibiting bone metastasis of tumor cells and method of screening for bone metastasis inhibitors |
KR101096359B1 (en) * | 2005-11-08 | 2011-12-20 | 제넨테크, 인크. | Neuropilin Antagonists |
KR20120048563A (en) * | 2009-06-22 | 2012-05-15 | 번햄 인스티튜트 포 메디칼 리서치 | Methods and compositions using peptides and proteins with c-terminal elements |
Non-Patent Citations (2)
Title |
---|
WILLIAMS ET AL.: "Identification of an Antibody Fragment Specific for Androgen-dependent Prostate Cancer Cells", BMC BIOTECHNOLOGY, vol. 4, 3 September 2014 (2014-09-03), pages 1 - 11, XP021195833 * |
WILLIAMS ET AL.: "In Vitro Selection of Cancer Cell -specific Molecular Recognition Elements from Amino Acid Libraries", JOURNAL OF IMMUNOLOGY RESEARCH, vol. 2015, 7 September 2015 (2015-09-07), pages 1 - 12, XP055556675 * |
Also Published As
Publication number | Publication date |
---|---|
WO2017209553A2 (en) | 2017-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020001879A (en) | Antigen-binding proteins tatrgeting shared antigens. | |
EP3471773A4 (en) | Cd3 binding antibodies | |
PH12018502225A1 (en) | Anti-il-33 antibodies, compositions, methods and uses thereof | |
EP3765522A4 (en) | Anti-claudin 18.2 antibodies | |
EP3411071A4 (en) | Novel cd47 monoclonal antibodies and uses thereof | |
WO2018109170A3 (en) | Il-11ra antibodies | |
WO2016077381A8 (en) | Anti-interleukin-33 antibodies and uses thereof | |
WO2017147542A3 (en) | Optimized transglutaminase site-specific antibody conjugation | |
AU2016219350A8 (en) | Humanized anti-MUC1* antibodies | |
WO2016073789A3 (en) | Anti-fgfr2/3 antibodies and methods using same | |
WO2017106684A3 (en) | Antibodies specifically binding hla-dr and their uses | |
PH12019502087A1 (en) | Anti-par2 antibodies and uses thereof | |
WO2015091853A3 (en) | Human anti-cd40 human antibodies | |
EP4017883A4 (en) | Novel anti-cldn18.2 antibodies | |
EP3824096A4 (en) | Novel antibodies and methods for making and using the same | |
WO2015127136A3 (en) | Ebola monoclonal antibodies | |
PH12019500551A1 (en) | Antibody specifically binding to il-17a and functional fragment thereof | |
MY189618A (en) | Antibody specifically binding to pd-1 and functional fragment thereof | |
WO2015200522A3 (en) | Monoclonal antibodies directed against envelope glycoproteins from multiple filovirus species | |
WO2018071910A3 (en) | Anti-il1-rap antibodies | |
WO2015075269A9 (en) | Antibodies against ccr9 and applications thereof | |
WO2015187018A3 (en) | Means and methods for determining t cell recognition | |
EP3692072A4 (en) | Anti-hla-dq2.5 antibody | |
WO2018138681A9 (en) | Hemagglutinin-specific antibodies and uses thereof | |
EP3947466A4 (en) | Anti-hla-dq2.5 antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17807046 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2018562986 Country of ref document: JP Kind code of ref document: A Ref document number: 3026236 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2017807046 Country of ref document: EP Effective date: 20190103 |
|
ENP | Entry into the national phase |
Ref document number: 2017273169 Country of ref document: AU Date of ref document: 20170602 Kind code of ref document: A |